These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
73 related articles for article (PubMed ID: 1319664)
41. The pattern of physical symptom changes in major depressive disorder following treatment with amitriptyline or imipramine. Casper RC; Katz MM; Bowden CL; Davis JM; Koslow SH; Hanin I J Affect Disord; 1994 Jul; 31(3):151-64. PubMed ID: 7963067 [TBL] [Abstract][Full Text] [Related]
42. Platelet serotonin and plasma tryptophan decreases in endogenous depression. Clinical, therapeutic, and biological correlations. Quintana J J Affect Disord; 1992 Feb; 24(2):55-62. PubMed ID: 1541767 [TBL] [Abstract][Full Text] [Related]
43. Reduced monoamine oxidase activity in blood platelets from bipolar depressed patients. Murphy DL; Weiss R Am J Psychiatry; 1972 May; 128(11):1351-7. PubMed ID: 5020182 [No Abstract] [Full Text] [Related]
44. The dexamethasone suppression test (DST) and platelet monoamine oxidase (MAO) activity as predictors of psychosis in depression. Bloomingdale KL; Vasile RG; Gudeman JE; Gerson B; Schildkraut JJ Biol Psychiatry; 1986 Apr; 21(4):390-3. PubMed ID: 3955113 [No Abstract] [Full Text] [Related]
45. Hypomania and tricyclic antidepressant choice. Steele TE; Taylor CI Am J Psychiatry; 1980 Nov; 137(11):1457-8. PubMed ID: 7435690 [No Abstract] [Full Text] [Related]
46. L-Deprenil, a selective monoamine oxidase type B inhibitor, in the treatment of depression: a double blind evaluation. Mendlewicz J; Youdim MB Br J Psychiatry; 1983 May; 142():508-11. PubMed ID: 6409196 [TBL] [Abstract][Full Text] [Related]
48. Platelet-monoamine-oxidase activity predicts response to lithium in manic-depressive illness. Sullivan JL; Cavenar JO; Maltbie A; Stanfield C Lancet; 1977 Dec 24-31; 2(8052-8053):1325-7. PubMed ID: 74733 [TBL] [Abstract][Full Text] [Related]
49. MAO inhibition and control of anxiety following amitriptyline therapy. A pilot study. Davidson J; Linnoila M; Raft D; Turnbull CD Acta Psychiatr Scand; 1981 Feb; 63(2):147-52. PubMed ID: 7234472 [TBL] [Abstract][Full Text] [Related]
50. What is the clinical significance of an elevated platelet MAO level? Pies RW J Clin Psychopharmacol; 1996 Dec; 16(6):472-3. PubMed ID: 8959484 [No Abstract] [Full Text] [Related]
51. Platelet MAO inhibition following tricyclic antidepressant therapy. Davidson J; Mcleod MN; Linnoila M; Kurland AA; White HL Am J Psychiatry; 1978 May; 135(5):603-5. PubMed ID: 645959 [No Abstract] [Full Text] [Related]
52. Absence of platelet monamine oxidase inhibition during amitriptyline or zimelidine treatment. Reveley MA; Glover V; Slander M; Coppen A Br J Clin Pharmacol; 1979 Oct; 8(4):375-8. PubMed ID: 508514 [No Abstract] [Full Text] [Related]
53. Plasma amine oxidase and clinical features of schizophrenia. Gruen R; Baron M; Levitt M; Kane J Am J Psychiatry; 1985 Aug; 142(8):972-3. PubMed ID: 4025599 [TBL] [Abstract][Full Text] [Related]